INFORMED: Creating a big data environment to enable data explorations that can yield groundbreaking scientific and regulatory insights.
The FDA Oncology Center of Excellence leverages the combined skills of regulatory scientists and reviewers with expertise in drugs, biologics, and devices (including diagnostics). This Center of Excellence will help expedite the development of oncology and hematology medical products and support an integrated approach in the clinical evaluation of drugs, biologics, and devices for the treatment of cancer. The OCE works with centers and offices across the FDA; visit Who We Are for more information.
- Upcoming OCE/Stakeholder Meetings
- Oncologic Drugs Advisory Committee
- Hematology/Oncology Approvals
- Follow @FDAOncology on Twitter
- Precision Oncology Program
- Patient-Focused Drug Development
- Pediatric Oncology
- Oncology Devices and Diagnostics
- Oncology Cell and Gene Therapy
- Oncology Regulatory Affairs
- Information for Sponsors
- Request an OCE speaker
- Jobs in Oncology/Hematology at FDA
- Physician Request for Single Patient IND for Compassionate or Emergency Use